Back
Royalty Pharma PLC Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
RPRX
Royalty Pharma PLC
Last Price:
$35.61
Seasonality Move:
-5.97%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RPRX is experiencing selling pressure, which indicates risk of future bearish movement.
Royalty Pharma PLC Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.91 | Sell |
20-day SMA: | 35.73 | Sell |
50-day SMA: | 34.28 | Buy |
200-day SMA: | 30.67 | Buy |
8-day EMA: | 29.79 | Buy |
20-day EMA: | 18.12 | Buy |
50-day EMA: | 8.78 | Buy |
200-day EMA: | 2.43 | Buy |
Royalty Pharma PLC Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 9.83 | Buy |
Relative Strength Index (14 RSI): | 52.75 | Buy |
Chaikin Money Flow: | -3752182 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.79 - 36.21) | Buy |
Bollinger Bands (100): | (31.98 - 34.86) | Buy |
Royalty Pharma PLC Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Royalty Pharma PLC Stock
Is Royalty Pharma PLC Stock a Buy?
-
Royalty Pharma PLC share price is 35.60 while RPRX 8-day simple moving average is 35.91, which is a Sell signal.
-
The stock price of RPRX is 35.60 while Royalty Pharma PLC 20-day SMA is 35.73, which makes it a Sell.
-
Royalty Pharma PLC 50-day simple moving average is 34.28 while RPRX share price is 35.60, making it a Buy technically.
-
RPRX stock price is 35.60 and Royalty Pharma PLC 200-day simple moving average is 30.67, creating a Buy signal.
RPRX Technical Analysis vs Fundamental Analysis
Sell
44
Royalty Pharma PLC (RPRX)
is a Sell
Is Royalty Pharma PLC a Buy or a Sell?
-
Royalty Pharma PLC stock is rated a SellThe current Royalty Pharma PLC [RPRX] share price is $35.60. The Score for RPRX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Royalty Pharma PLC Stock Info
Market Cap:
15B
Price in USD:
35.60
Share Volume:
3.8M
Royalty Pharma PLC 52-Week Range
52-Week High:
36.69
52-Week Low:
24.05
Sell
44
Royalty Pharma PLC (RPRX)
is a Sell
Royalty Pharma PLC Share Price Forecast
-
What is the Royalty Pharma PLC stock price today?The Royalty Pharma PLC stock price is 35.60 USD today.
-
Will RPRX stock go up or go down?Royalty Pharma PLC> share price is forecast to RISE/FALL based on technical indicators
-
Is Royalty Pharma PLC overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Royalty Pharma PLC is overvalued.
Is Royalty Pharma PLC Stock a Buy?
-
Royalty Pharma PLC share price is 35.60 while RPRX 8-day exponential moving average is 29.79, which is a Buy signal.
-
The stock price of RPRX is 35.60 while Royalty Pharma PLC 20-day EMA is 18.12, which makes it a Buy.
-
Royalty Pharma PLC 50-day exponential moving average is 8.78 while RPRX share price is 35.60, making it a Buy technically.
-
RPRX stock price is 35.60 and Royalty Pharma PLC 200-day simple moving average is 2.43, creating a Buy signal.
Fundamental Analysis of Royalty Pharma PLC
Is Royalty Pharma PLC a good investment?
-
Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.38 per share, an increase this year of $0.35 per share, and an increase next year of $0.63 per share.
Technical Analysis of Royalty Pharma PLC
Should I short Royalty Pharma PLC stock?
-
RPRX Moving Average Covergence Divergence (MACD) indicator is 9.83, suggesting Royalty Pharma PLC is a Buy
-
Royalty Pharma PLC Relative Strength Index (RSI) is 52.75, which suggest Royalty Pharma PLC is overbought
-
The Bollinger Bands (25) for Royalty Pharma PLC is (34.79 - 36.21), which suggest Royalty Pharma PLC is a Buy
-
The Bollinger Bands (100) for Royalty Pharma PLC is (31.98 - 34.86), which suggest Royalty Pharma PLC is a Buy
* Royalty Pharma PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.